Andrew Coles is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of drug delivery devices, holding 3 patents that showcase his innovative approach to medical technology.

Latest Patents

One of his latest patents is for an autoinjector with stall and endpoint detection. This device is designed to enhance drug delivery by incorporating a detection algorithm that accounts for variations in the drug fill, barrel, plunger, and other components. The stall or endpoint detection feature ensures that the autoinjector stops the extrusion process at the appropriate time, improving the reliability of drug administration.

Another patent focuses on a door latch mechanism for a drug delivery device. This invention includes a housing that defines a shell and an inner volume, along with a cassette that contains the drug to be administered. The door is coupled to the housing and features a latching portion that secures the door during operation. The drive mechanism exerts force to dispense the drug, while the latching assembly engages the door to ensure safety and efficiency in drug delivery.

Career Highlights

Andrew Coles is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to develop innovative solutions that address critical needs in drug delivery systems. His contributions have been instrumental in advancing the capabilities of medical devices.

Collaborations

Throughout his career, Andrew has collaborated with talented individuals such as Antonio Antonini and Emanuele Strada. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Andrew Coles exemplifies the spirit of innovation in the medical technology field. His patents reflect a commitment to improving drug delivery systems, ultimately enhancing patient care. His work at Amgen and collaborations with other professionals further underscore his impact on the industry.